Indegene

Indegene Goodwill

The Goodwill of Indegene (INDGN.NS) as of Oct 22, 2026 is 11.34 B INR. In the previous year, Goodwill was 3.57 B INR — a change of 218.18% (higher).

Goodwill

11.34 BINR

YoY

218.18%

Last updated:

Goodwill of Indegene is 2026 11.34 B INR. Goodwill of Indegene was 2025 3.57 B INR. It decreases by 218.18% higher compared to the previous year.

The Indegene Goodwill history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Goodwill
Date
Goodwill
Jan 1, 2020
530.24 M INR
Jan 1, 2021
290.09 M INR
Jan 1, 2022
408.97 M INR
Jan 1, 2023
3.26 B INR
Jan 1, 2024
3.33 B INR
Jan 1, 2025
3.57 B INR
Jan 1, 2026
11.34 B INR
The Indegene Goodwill history
YEARGoodwillYoY
11.34 BINR+218.18%
3.57 BINR+7.06%
3.33 BINR+2.11%
3.26 BINR+697.42%
408.97 MINR+40.98%
290.09 MINR-45.29%
530.24 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Indegene Stock analysis

What does Indegene do? Indegene Ltd generates revenue by providing digital-led commercialization services to life sciences companies, including biopharmaceutical, emerging biotech, and medical devices firms. The company assists these clients with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and the sales and marketing of their products. This comprehensive support structure allows Indegene to serve as a key partner in the end-to-end commercialization process for its diverse client base within the life sciences sector. The company monetizes its offerings through specialized solution segments such as Omnichannel Activation, which helps life sciences companies leverage a digital first approach for optimizing the last-mile promotion of biopharmaceutical products and medical devices to healthcare professionals across multiple channels. Additionally, Enterprise Commercial Solutions primarily involves assisting life sciences companies with their digital marketing operations, further expanding the company's service portfolio and revenue streams. Revenue is also derived from Enterprise Medical Solutions, where Indegene establishes centers of excellence to consolidate large scale regulatory and medical operations for its clients. The company rounds out its business model by offering enterprise clinical solutions and consultancy services, ensuring a holistic service delivery model that addresses various operational needs of its customers in the life sciences industry. Indegene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Indegene stock

Goodwill of Indegene is 11.34 B INR in 2026.

Goodwill of Indegene changed from 3.57 B INR to 11.34 B INR, representing a 218.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Goodwill Indegene since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's Indegene historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Indegene

All Key Metrics — Indegene